Archives
-
DiscoveryProbe Immunology/Inflammation Compound Library
2026-09-10
Turn a 295-compound collection into a multiparametric PBMC screening workflow that separates immune modulation from nonspecific toxicity. The approach combines target-oriented controls with proliferation, activation, and B-cell costimulatory readouts for more actionable inflammation research.
-
Cimetidine: H2 Biology Meets BBB Assays
2026-09-10
Cimetidine is more than a conventional histamine-2 receptor antagonist: its partial H2 receptor pharmacology creates a useful probe for separating receptor biology from barrier transport. This article translates a modern BBB surrogate model into practical assay decisions for cancer research and gastrointestinal pharmacology.
-
BV6 IAP Antagonist: Workflow for Apoptosis Studies
2026-09-09
BV6 provides a practical way to interrogate IAP-dependent survival, apoptosis induction in cancer cells, and therapy sensitization across cell and animal models. This workflow combines dose-response design with orthogonal pathway and phenotype readouts, while using the reference study to prevent overinterpreting caspase or mitochondrial signals.
-
Sulfo-NHS-SS-Biotin: Practical Labeling Guide
2026-09-09
Sulfo-NHS-SS-Biotin is a water-compatible reagent for labeling primary amines on proteins and cell-surface molecules, with a disulfide linker that supports downstream cleavage by reducing agents. It is appropriate for fresh aqueous labeling workflows and affinity capture, but should not be stored after dissolution or exposed to reducing conditions before biotin-dependent purification.
-
N1-Methylpseudo-UTP for Translational RNA
2026-09-08
N1-Methyl-Pseudouridine-5'-Triphosphate is more than a substituted uridine building block: it is a design variable for balancing RNA stability, innate immune visibility, translation, and analytical confidence. This thought-leadership article connects mechanistic evidence with practical in vitro transcription decisions and translational strategy.
-
NVP-BGJ398 Phosphate: FGFR3 Assay Logic
2026-09-08
NVP-BGJ398 phosphate is a potent FGFR1–3 research inhibitor with applications spanning oncogenic signaling and SLC26A2-related skeletal disease. This article focuses on how to design, interpret, and translate FGFR perturbation assays rather than simply summarizing compound activity.
-
CGRP Restrains CD4+ T Cells in Allergic Sensitization
2026-09-07
Li et al. identify CGRP–RAMP1 signaling as an intrinsic brake on CD4+ T-cell activation, differentiation, and Tfh accumulation during house dust mite-induced allergic sensitization. Through complementary genetic, imaging, transfer, and multi-omics approaches, the study connects sensory-nerve activity with lymph-node adaptive immunity and shows that exogenous CGRP can reduce allergic sensitization when administered during the preventive phase.
-
TCAIM Controls OGDH and Mitochondrial Metabolism
2026-09-07
Wang et al. identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The study establishes mitochondrial proteostasis as a post-translational mechanism for suppressing OGDH complex activity and reshaping carbohydrate catabolism in cells and mice.
-
Geneticin: G418 Sulfate Selection Workflow
2026-09-05
Build cleaner stable cell models with Geneticin, G418 Sulfate, using a staged kill-curve workflow, resistance-aware maintenance, and assay controls. The same reagent also supports exploratory Dengue virus inhibition studies, while careful cytotoxicity controls help distinguish selection effects from biology.
-
PDHA1 Acetylation, Cuproptosis, and Enzalutamide Resistance
2026-09-04
The 2026 reference study identifies a PDHA1–acetyl-CoA–H3K27ac–SLC7A11 axis that suppresses cuproptosis and weakens enzalutamide activity in castration-resistant prostate cancer. Its combined cellular, metabolic, epigenetic, and in vivo evidence positions PDHA1 inhibition as a strategy for reactivating copper-dependent cell death, while also defining important limits for translation.
-
Anlotinib hydrochloride: Reliable Assay Design
2026-09-04
Anlotinib hydrochloride (SKU C8688) offers a data-backed approach to separating anti-angiogenic signaling effects from nonspecific cytotoxicity in cell-based assays. This scenario-driven guide covers assay design, protocol optimization, interpretation, and practical product selection for cancer research.
-
Cy7 NHS Ester: Practical Labeling Workflow
2026-09-03
Cy7 NHS ester is a water-soluble amino-group labeling reagent for preparing protein and peptide conjugates used in near-infrared fluorescent imaging. It is best suited to biomolecules with accessible amines and fresh-solution workflows, but it should not be selected when targets lack reactive amino groups or when long-term storage of the dye solution is required.
-
1-myristoylglycerophosphocholine in Fibrosis Assays
2026-09-03
Use 1-myristoylglycerophosphocholine, also known as 14:0 Lyso-PC, as a defined lysophospholipid challenge for connecting epithelial lipid remodeling with fibroblast activation. This practical guide translates the HMGCS2–LysoPC pulmonary fibrosis findings into controlled cell-based workflows while preserving a separate, hypothesis-driven path for smooth muscle research.
-
SCP4 and H3T3 Dephosphorylation in Mitosis
2026-09-02
The reference study identifies SCP4 as a nuclear phosphatase that removes mitotic histone H3 threonine 3 phosphorylation, a modification previously understood mainly through the action of Haspin. By linking SCP4 activity to chromosomal passenger complex recruitment, chromosome segregation, aneuploidy, and early embryonic cleavage, the work expands the regulatory framework for mitotic fidelity.
-
Cyclosporin A (B1922): Practical Lab Guide
2026-09-02
Cyclosporin A, also known as cyclosporine, provides a defined cyclophilin-directed perturbation for studies of T-cell activation, mitochondrial function, apoptosis modulation, viral entry inhibition, and retinal ischemic injury. It is appropriate for workflows that can accommodate an organic-solvent stock, but should not be selected for aqueous-only protocols or experiments requiring unqualified long-term solution stability.